News

Notice to the Annual General Meeting in IRLAB Therapeutics AB
GOTHENBURG, SE / ACCESS Newswire / May 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - IRLAB Therapeutics AB, reg. no ...
IRLAB: Invitation to the Interim Report for Q1 2025 Presentation and Webcast
GOTHENBURG, SE / ACCESS Newswire / May 6, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 6, 2025 ...
IRLAB Therapeutics: IRLAB Publishes Interim Report for the Period January - March 2025
GOTHENBURG, SE / ACCESS Newswire / May 7, 2025 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that t ...